Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Inozyme Pharma Inc.
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
April 08, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 05, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
March 26, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
March 12, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference
February 26, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2024
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Participate in Upcoming Investor Conferences
November 09, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
November 07, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023
October 26, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
October 10, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting
October 06, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)
September 26, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023
September 20, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
August 08, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 03, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma, Inc. Announces Closing of Public Offering of Common Stock
August 01, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
July 27, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock
July 27, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
July 26, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
July 19, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Announces Dosing of First Infant with ENPP1 Deficiency in a Phase 1b Trial of INZ-701
June 27, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
May 09, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Inozyme Pharma to Present Recently Announced Preliminary Data from Ongoing Phase 1/2 Trial in ENPP1 Deficiency at the European Calcified Tissue Society Congress (ECTS)
April 14, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.